Displaying 21 to 40 of 64 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Hyperion Therapeutics Inc Hyperion Therapeutics is a privately held specialty pharmaceutical company focused on the development of therapies that address critical unmet needs i |
United States | N/A |
||
|
|
IDEV Technologies Inc Developer of next generation medical devices for use in the interventional radiology, vascular surgery, and cardiology device marketplace. |
United States | N/A |
||
|
|
Ingenuity Systems Inc |
United States | N/A Active |
||
|
Intarcia Therapeutics Inc A biopharmaceutical company applying a targeted approach to the acquisition, development and commercialization of novel therapeutic products for the t |
United States | N/A |
||
|
|
Ion Torrent Systems Inc ION Torrent Systems pioneered an entirely new approach to sequencing that enables a direct connection between chemical and digital information. |
United States | N/A Initial investment. Round participant. Exited (Trade sale) |
||
|
|
Itamar Medical Ltd Develops a minimally invasive diagnostic that measures through a finger probe the Peripheral Arterial Tone (PAT) signal. |
Israel | N/A |
||
|
|
Lexicon Pharmaceuticals Inc Designs and develops high throughput mutagenesis technologies for studying functional genomics in mammalian systems. |
United States | N/A |
||
|
|
LJL BioSystems Inc Proprietary instrumentation and consumables for high throughput and ultra-high throughput screening for drug discovery. |
United States | N/A |
||
|
|
Madrigal Pharmaceuticals Inc Drug development company focused on building a pipeline of small-molecule drugs for the treatment of cardiovascular and metabolic diseases. |
United States | N/A |
||
|
|
MAP Pharmaceuticals Inc Proprietary inhalation technologies to enhance the therapeutic benefits and commercial attractiveness of proven drugs. |
United States | N/A |
||
|
|
Maxia Pharmaceuticals Inc Formed to exploit the non-dermatological applications of a patented library of compounds licensed from Galderma. |
United States | N/A |
||
|
|
Medarex Inc Creates and develops therapeutic products for cancer, autoimmune disease and other life-threatening and debilitating diseases. |
United States | N/A |
||
|
|
Merus Biopharmaceuticals BV Dutch antibody company focused on the use of two proprietary technologies to build a pipeline of innovative human therapeutic antibodies: the Oligoclo |
Netherlands | N/A |
||
|
|
Metabolex Inc Focuses on the discovery and development of novel therapeutics for the treatment of diabetes. |
United States | 1 Apr 2007 | Series D |
|
|
|
Metabolex Inc Focuses on the discovery and development of novel therapeutics for the treatment of diabetes. |
United States | 1 Nov 2009 | N/A |
|
|
|
Nevro Corp Medical device company marketing novel neuromodulation therapies for the treatment of chronic, intractable pain. |
United States | 1 Jul 2011 | N/A |
|
|
|
Nevro Corp Medical device company marketing novel neuromodulation therapies for the treatment of chronic, intractable pain. |
United States | 1 Aug 2008 | Series A |
|
|
|
Nextwave Pharmaceuticals Inc Specialty pharmaceutical company, focused on pediatric neurology. |
United States | N/A Active |
||
|
|
Nextwave Pharmaceuticals Inc Specialty pharmaceutical company, focused on pediatric neurology. |
United States | N/A Active |
||
|
|
Nexus Dx Inc |
United States | N/A |